UGC approved journal IJNRD Research Journal


INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD)
An International Open Access Journal |   ISSN: 2456-4184 |  IMPACT FACTOR: 5.57

Call For Paper

Issue: September 2020

Volume 5 | Issue 9

Impact Factor: 5.57

Submit Paper Online

Click Here For more Details

For Authors

Forms / Download

Editorial Board

Subscribe IJNRD

Facts & Figure

Impact Factor : 5.57

Issue per Year : 12

Volume Published : 5

Issue Published : 52

Article Submitted : 636

Article Published : 379

Total Authors : 993

Total Reviewer : 550

Total Pages : 79

Total Countries : 24

Visitor Counter


Indexing Partner

Published Paper Details
Paper Title: BRIEF STUDY AND THEIR PREFORMULATION PARAMETERS ON A DRUG: TENOFOVIR DISOPROXIL FUMARATE
Authors Name: Pratima jayasawal , Dr N.G. Raghavendra Rao , Dr. Pranshu tangri , Jyoti saxena
Author Reg. ID:
IJNRD_180317
Published Paper Id: IJNRD2006035
Published In: Volume 5 Issue 6, June-2020
Abstract: Tenofovir disoproxil fumarate (tenofovir DF) is a bioavailable prodrug of tenofovir, a potent nucleotide analogue reverse-transcriptase inhibitor with activity against human immunodeficiency virus (HIV) and hepatitis B virus. It is administered as a single 300-mg tablet once daily. It was approved for the treatment of HIV infection on the basis of data from clinical trials demonstrating activity in treatment-experienced patients, and it was subsequently shown to be effective when used as a component of initial therapy. Tenofovir DF is active against some nucleoside-resistant strains of HIV. However, cross-resistance is associated with multiple thymidine analogue mutations that include 41L or 210W. The signature mutation is the K65R mutation, which causes variable loss in susceptibility to tenofovir DF, didanosine, and abacavir. Tenofovir DF has been well tolerated in clinical trials with durations of follow-up up to 96 weeks. It is associated with more-favorable lipid profiles than stavudine and has not been associated with the mitochondrial toxicity attributed to other nucleoside analogues.
Keywords: Tenofovir , Hiv , nrti
Cite Article: "BRIEF STUDY AND THEIR PREFORMULATION PARAMETERS ON A DRUG: TENOFOVIR DISOPROXIL FUMARATE", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.5, Issue 6, page no.314-325, June-2020, Available :http://www.ijnrd.org/papers/IJNRD2006035.pdf
Downloads: 000174
Share Article:

Click Here to Download This Article

Article Preview

ISSN Details

DOI (A digital object identifier)



Providing A digital object identifier by DOI

RMS

Conference Proposal

Latest News / Updates

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

IJNRD